YEAR
- 2017.11.10 Real-space and real-time dynamics of CRISPR-Cas9 visualized by high-speed atomic force microscopy Shibata M, Nishimasu H, Kodera N, Hirano S, Ando T, Uchihashi T, Nureki O.Nat Commun. 2017 11 10;8(1):1430. doi: 10.1038/s41467-017-01466-8
- 2017.09.19 Plasma Irradiation Effects to Intra-Abdominal Organ Compared with Adhesion Mouse Model. Keita Soda, Hiroharu Yamashita, Kyungho Chang, Takeshi Kawamura, Takao Hamakubo and Nobuyuki Shimizu.Plasma Medicine. 2017, 7(4):347–381
- 2017.09.19 Fine-tuning type I IFN signaling: A new chapter in the IFN saga. Yanai H, Taniguchi T.Cell Res. 2017 12;27(12):1407-1408. doi: 10.1038/cr.2017.118
- 2017.09.06 Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis. Sarashina-Kida H, Negishi H, Nishio J, Suda W, Nakajima Y, Yasui-Kato M, Iwaisako K, Kang S, Endo N, Yanai H, Asagiri M, Kida H, Hattori M, Kumanogoh A, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2017 09 19;114(38):10178-10183. doi: 10.1073/pnas.1712837114
- 2017.09.01 Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Takayanagi S, Mukasa A, Tanaka S, Nomura M, Omata M, Yanagisawa S, Yamamoto S, Ichimura K, Nakatomi H, Ueki K, Aburatani H, Saito N.Neuro-oncology. 2017 09 01;19(9):1228-1236. doi: 10.1093/neuonc/nox034
- 2017.08.09 Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6 Taniguchi, R., Inoue, A., Sayama, M., Uwamizu, A., Yamashita, K., Hirata, K., Yoshida, M., Tanaka, Y., Kato, H.E., Nakada-Nakura, Y., Otani, Y., Nishizawa, T., Doi, T., Ohwada, T., Ishitani, R., Aoki, J., Nureki, O.Nature. 548, 356-60 (2017)
- 2017.08.03 Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1 Yamano T, Zetsche B, Ishitani R, Zhang F, Nishimasu H, Nureki OMol. Cell. 2017 Aug 17;67(4):633-645.e3. doi: 10.1016/j.molcel.2017.06.035.
- 2017.06.08 Yeast genetic interaction screen of human genes associated with amyotrophic lateral sclerosis: identification of MAP2K5 kinase as a potential drug target. Jo M, Chung AY, Yachie N, Seo M, Jeon H, Nam Y, Seo Y, Kim E, Zhong Q, Vidal M, Park HC, Roth FP, Suk K.Genome Res. 2017 09;27(9):1487-1500. doi: 10.1101/gr.211649.116
CLOSE